Financials
- Market Capitalization 11.49 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-37.39
売上高対価格比率
16.85
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 815 | CORT Corcept Therapeutics Incorporated - Common Stock | 112.95 USD | -0.82% | -7.65% | -1.06% | +53.95% | 12.21 B USD | ||
| 817 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.22 USD | +0.83% | -1.26% | +28.60% | +59.01% | 12.06 B USD | ||
| 850 | TECH Bio-Techne Corp - Common Stock | 72.32 USD | -0.04% | -0.04% | +0.25% | +33.51% | 11.34 B USD | ||
| 871 | SMMT Summit Therapeutics Inc. - Common Stock | 13.55 USD | -1.31% | +7.11% | +4.63% | -31.77% | 10.81 B USD |